• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY (BD) BD A-LINE¿; BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY (BD) BD A-LINE¿; BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Catalog Number 364356
Medical Device Problem Code Coagulation in Device or Device Ingredient (1096)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/20/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
There were multiple lot numbers reported to be involved.The information for each additional lot number is as follows: d4.Medical device lot#: 3151661 d4.Medical device expiration date: 30-jun-2025 h4.Device manufacture date: 31-may-2023 d4.Medical device lot#: unknown d4.Medical device expiration date: unknown h4.Device manufacture date: unknown b3: date of event is unknown.The date received by manufacturer has been used for this field.H.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported that while using bd a-line¿, clotting was seen in 5 syringes with a known lot number and an unspecified number of syringes with unknown lot numbers.No patient impact reported.
 
Event or Problem Description
It was reported that while using bd a-line¿, clotting was seen in 5 syringes with a known lot number and an unspecified number of syringes with unknown lot numbers.No patient impact reported.
 
Additional Manufacturer Narrative
H.6 investigation summary.Material #: 364356.Lot/batch #: 3151661 and unknown.Bd had not received samples, but 2 photos were provided for investigation.The photos were reviewed and the indicated failure mode for clotting with the incident lot was not observed.Additionally, (b)(4) retention samples from bd inventory were evaluated for their heparin content and no issues were observed relating to clotting as all samples met specifications.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure mode clotting.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD A-LINE¿
Common Device Name
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK 
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY (BD)
belliver way
belliver industrial estate
plymouth
UK  
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18902938
Report Number9617032-2024-00364
Device Sequence Number18114526
Product Code JKA
UDI-Device Identifier50382903643566
UDI-Public(01)50382903643566
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K022426
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number364356
Device Lot NumberSEE H.10
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/20/2024
Supplement Date Received by Manufacturer04/03/2024
Initial Report FDA Received Date03/14/2024
Supplement Report FDA Received Date04/18/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured05/31/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-